Renbio

Developer of antibody-based therapeutic solutions for the treatment of cancer & inflammatory diseases

placeNew York City, New York, United States calendar_todayFounded 2016 groups10 employees language renbio.com

Registered entities

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating.

Social engagement

Social engagement: 2K social following, 8 posts in the last 12 months — below the industry typical range.

Recent activity

9 Jan 2026
Event
Biotech Showcase
8 Jan 2026
Event
Princeton Alumni BioPharma Forum
25 Sep 2025
Event
Obesity Drug Development Summit Europe
Coming soon